Sources | Names Used |
---|---|
GDSC1000 | MPS-1-IN-1 |
PharmacoGx | MPS-1-IN-1 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LMLN | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
mRNA | OR8I2 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
mRNA | MAP2K3 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
mRNA | PIM3 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
mRNA | MFGE8 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
mRNA | ACIN1 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
mRNA | PRKAB2 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
mRNA | POU4F2 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
mRNA | RBM26 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | UBXN6 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |